Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Möchten Sie über diese Zeitschrift informiert bleiben? Klicken Sie bitte auf die Buttons, um unsere Alerts zu abonnieren.
Combination of heat-killed Lactiplantibacillus plantarum YIT 0132 (LP0132) and oral immunotherapy in cowâs milk allergy: a randomised controlled trial
in Beneficial MicrobesSearch for other papers by K. Yamamoto-Hanada in
Current site
Google Scholar
Search for other papers by M. Sato in
Current site
Google Scholar
Search for other papers by K. Toyokuni in
Current site
Google Scholar
Search for other papers by M. Irahara in
Current site
Google Scholar
Search for other papers by E. Hiraide-Kotaki in
Current site
Google Scholar
Search for other papers by N. Harima-Mizusawa in
Current site
Google Scholar
Search for other papers by H. Morita in
Current site
Google Scholar
Search for other papers by K. Matsumoto in
Current site
Google Scholar
Search for other papers by Y. Ohya in
Current site
Google Scholar
Safer and more effective cow milk (CM)-oral immunotherapy that does not induce allergic reactions has not yet been standardised. We sought to explore the efficacy and feasibility of a combination of heat-killed Lactiplantibacillus plantarum YIT 0132 (LP0132) and oral immunotherapy for treating IgE-mediated cow milk allergy (CMA). We conducted a 24-week, double-blind, randomised (1:1), two-arm, parallel-group, placebo-controlled, phase 2 trial of LP0132 intervention for treating IgE-mediated CMA in children aged 1-18 years (n=60) from January 29, 2018 to July 12, 2019 in Tokyo, Japan. Participants were randomly assigned to the LP0132 group receiving citrus juice fermented with LP0132 or to the control group receiving citrus juice without. Both groups received low-dose slow oral immunotherapy with CM. The primary outcome was improved tolerance to CM, proven by the CM challenge test at 24 weeks. Secondary outcomes were changes in serum biomarkers of serum-specific β-lactoglobulin-IgE (sIgE) and β-lactoglobulin-IgG4 (sIgG4). Exploratory outcomes included changes in serum cytokine levels and gut microbiota composition. A total of 61 participants were included. Finally, 31 children were assigned to the LP0132 group and 30 to the control group, respectively. After the intervention, 41.4 and 37.9% of the participants in the LP0132 and control groups, respectively, showed improved tolerance to CM. In serum biomarkers after the intervention, the sIgG4 level was significantly higher, and interleukin (IL)-5 and IL-9 were significantly lower, in the LP0132 group than in the control group. In the gut microbiome, the α-diversity and Lachnospiraceae increased significantly in the LP0132 group, and Lachnospiraceae after the intervention was significantly higher in the LP0132 group than in the control group. In conclusion, low-dose oral immunotherapy with modulating gut microbiota might be a safer and more effective approach for treating cowâs milk allergy.
-
Berin, M.C., 2021. Dysbiosis in food allergy and implications for microbial therapeutics. Journal of Clinical Investigation 131: e144994. https://doi.org/10.1172/jci144994
-
Berni Canani, R., Di Costanzo, M., Bedogni, G., Amoroso, A., Cosenza, L., Di Scala, C., Granata, V. and Nocerino, R., 2017. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cowâs milk allergy: 3-year randomized controlled trial. Journal of Allergy and Clinical Immunology 139: 1906-1913.e1904. https://doi.org/10.1016/j.jaci.2016.10.050
-
Berni Canani, R., Nocerino, R., Terrin, G., Coruzzo, A., Cosenza, L., Leone, L. and Troncone, R., 2012. Effect of Lactobacillus GG on tolerance acquisition in infants with cowâs milk allergy: a randomized trial. Journal of Allergy and Clinical Immunology 129: 580-582, 582. e581-585. https://doi.org/10.1016/j.jaci.2011.10.004
-
Berni Canani, R., Sangwan, N., Stefka, A.T., Nocerino, R., Paparo, L., Aitoro, R., Calignano, A., Khan, A.A., Gilbert, J.A. and Nagler, C.R., 2016. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME Journal 10: 742-750. https://doi.org/10.1038/ismej.2015.151
-
Blumchen, K., Trendelenburg, V., Ahrens, F., Gruebl, A., Hamelmann, E., Hansen, G., Heinzmann, A., Nemat, K., Holzhauser, T., Roeder, M., Rosenfeld, L., Hartmann, O., Niggemann, B. and Beyer, K., 2019. Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy. Journal of Allergy and Clinical Immunology in Practice 7: 479-491.e4. https://doi.org/10.1016/j.jaip.2018.10.048
-
Brozek, J.L., Terracciano, L., Hsu, J., Kreis, J., Compalati, E., Santesso, N., Fiocchi, A. and Schünemann, H.J., 2012. Oral immunotherapy for IgE-mediated cowâs milk allergy: a systematic review and metaanalysis. Clinical and Experimental Allergy 42: 363-374. https://doi.org/10.1111/j.1365-2222.2011.03948.x
-
Bunyavanich, S., Shen, N., Grishin, A., Wood, R., Burks, W., Dawson, P., Jones, S.M., Leung, D.Y.M., Sampson, H., Sicherer, S. and Clemente, J.C., 2016. Early-life gut microbiome composition and milk allergy resolution. Journal of Allergy and Clinical Immunology 138: 1122-1130. https://doi.org/10.1016/j.jaci.2016.03.041
-
De Schryver, S., Mazer, B., Clarke, A.E., St Pierre, Y., Lejtenyi, D., Langlois, A., Torabi, B., Zhao, W.W., Chan, E.S., Baerg, I. and Ben-Shoshan, M., 2019. Adverse events in oral immunotherapy for the desensitization of cowâs milk allergy in children: a randomized controlled trial. Journal of Allergy and Clinical Immunology in Practice 7: 1912-1919. https://doi.org/10.1016/j.jaip.2019.02.007
-
De Souza da Motta, A., Nespolo, C.R. and Breyer, G.M., 2022. Probiotics in milk and dairy foods. In: Brandelli, A. (ed.), Probiotics. Academic Press, Cambridge, MA, USA, pp. 103-128. https://doi.org/10.1016/B978-0-323-85170-1.00004-X
-
Fang, Z., Lu, W., Zhao, J., Zhang, H., Qian, L., Wang, Q. and Chen, W., 2020. Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study. European Journal of Nutrition 59: 2119-2130. https://doi.org/10.1007/s00394-019-02061-x
-
Flom, J.D. and Sicherer, S.H., 2019. Epidemiology of cowâs milk allergy. Nutrients 11: 1051. https://doi.org/10.3390/nu11051051
-
Gao, J., Li, X., Zhang, G., Sadiq, F.A., Simal-Gandara, J., Xiao, J. and Sang, Y., 2021. Probiotics in the dairy industry â Advances and opportunities. Comprehensive Reviews in Food Science and Food Safety 20: 3937-3982.
'Probiotics in the dairy industry â Advances and opportunities ' () 20 Comprehensive Reviews in Food Science and Food Safety : 3937 -3982.
-
Güvenç, I.A., Muluk, N.B., Mutlu, F., EÅki, E., Altintoprak, N., Oktemer, T. and Cingi, C., 2016. Do probiotics have a role in the treatment of allergic rhinitis? A comprehensive systematic review and metaanalysis. American Journal of Rhinology and Allergy 30: 157-175. https://doi.org/10.2500/ajra.2016.30.4354
-
Hardy, L.C., Smeekens, J.M. and Kulis, M.D., 2019. Biomarkers in food allergy immunotherapy. Current Allergy and Asthma Reports 19: 61. https://doi.org/10.1007/s11882-019-0894-y
-
Harima-Mizusawa, N., Iino, T., Onodera-Masuoka, N., Kato-Nagaoka, N., Kiyoshima-Shibata, J., Gomi, A., Shibahara-Sone, H., Kano, M., Shida, K., Sakai, M., Miyazaki, K. and Ishikawa, F., 2014. Beneficial effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis. Bioscience of Microbiota, Food and Health 33: 147-155. https://doi.org/10.12938/bmfh.33.147
-
Harima-Mizusawa, N., Kamachi, K., Kano, M., Nozaki, D., Uetake, T., Yokomizo, Y., Nagino, T., Tanaka, A., Miyazaki, K. and Nakamura, S., 2016a. Beneficial effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on atopic dermatitis: results of daily intake by adult patients in two open trials. Bioscience of Microbiota, Food and Health 35: 29-39. https://doi.org/10.12938/bmfh.2015-010
-
Harima-Mizusawa, N., Kano, M., Nozaki, D., Nonaka, C., Miyazaki, K. and Enomoto, T., 2016b. Citrus juice fermented with Lactobacillus plantarum YIT 0132 alleviates symptoms of perennial allergic rhinitis in a double-blind, placebo-controlled trial. Beneficial Microbes 7: 649-658. https://doi.org/10.3920/bm2016.0003
-
He, Z., Vadali, V.G., Szabady, R.L., Zhang, W., Norman, J.M., Roberts, B., Tibshirani, R., Desai, M., Chinthrajah, R.S., Galli, S.J., Andorf, S. and Nadeau, K.C., 2021. Increased diversity of gut microbiota during active oral immunotherapy in peanut-allergic adults. Allergy 76: 927-930. https://doi.org/10.1111/all.14540
-
Hol, J., van Leer, E.H., Elink Schuurman, B.E., de Ruiter, L.F., Samsom, J.N., Hop, W., Neijens, H.J., de Jongste, J.C. and Nieuwenhuis, E.E., 2008. The acquisition of tolerance toward cowâs milk through probiotic supplementation: a randomized, controlled trial. Journal of Allergy and Clinical Immunology 121: 1448-1454.https://doi.org/10.1016/j.jaci.2008.03.018
-
Huang, Y.J., Marsland, B.J., Bunyavanich, S., OâMahony, L., Leung, D.Y., Muraro, A. and Fleisher, T.A., 2017. The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. Journal of Allergy and Clinical Immunology 139: 1099-1110. https://doi.org/10.1016/j.jaci.2017.02.007
-
Jing, W., Liu, Q. and Wang, W., 2020. Bifidobacterium bifidum TMC3115 ameliorates milk protein allergy in by affecting gut microbiota: A randomized double-blind control trial. Journal of Food Biochemistry 44: e13489. https://doi.org/10.1111/jfbc.13489
-
Kakiyama, S., Kubota, N., Shida, K. and Harima-Mizusawa, N., 2020. Effects of citrus juice fermented with Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis during probiotic consumption: an open study. Bioscience of Microbiota, Food and Health 39: 137-144. https://doi.org/10.12938/bmfh.2019-017
-
Kucuksezer, U.C., Ozdemir, C., Cevhertas, L., Ogulur, I., Akdis, M. and Akdis, C.A., 2020. Mechanisms of allergen-specific immunotherapy and allergen tolerance. Allergology International 69: 549-560. https://doi.org/10.1016/j.alit.2020.08.002
-
Lee, J.H., Kim, W.S., Kim, H. and Hahn, Y.S., 2013. Increased cowâs milk protein-specific IgG4 levels after oral desensitization in 7- to 12-month-old infants. Annals of Allergy, Asthma, and Immunology 111: 523-528. https://doi.org/10.1016/j.anai.2013.09.001
-
Loh, W. and Tang, M.L.K., 2018. The epidemiology of food allergy in the global context. International Journal of Environmental Research and Public Health 15: 2043. https://doi.org/10.3390/ijerph15092043
-
Loke, P., Chebar Lozinsky, A., Orsini, F., Wong, L.S., Leung, A.S., Tham, E.H., Lopata, A.L., Shek, L.P. and Tang, M.L., 2021. Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study). BMJ Open 11: e044331. https://doi.org/10.1136/bmjopen-2020-044331
-
Loke, P., Orsini, F., Lozinsky, A.C., Gold, M., OâSullivan, M.D., Quinn, P., Lloyd, M., Ashley, S.E., Pitkin, S., Axelrad, C., Metcalfe, J.R., Su, E.L., Tey, D., Robinson, M.N., Allen, K.J., Prescott, S.L., Galvin, A.D. and Tang, M.L.K., 2022. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial. The Lancet Child ands Adolescent Health 6: 171-184. https://doi.org/10.1016/s2352-4642(22)00006-2
-
Martorell, A., De la Hoz, B., Ibáñez, M.D., Bone, J., Terrados, M.S., Michavila, A., Plaza, A.M., Alonso, E., Garde, J., Nevot, S., Echeverria, L., Santana, C., Cerdá, J.C., Escudero, C., Guallar, I., Piquer, M., Zapatero, L., Ferré, L., Bracamonte, T., Muriel, A., MartÃnez, M.I. and Félix, R., 2011. Oral desensitization as a useful treatment in 2-year-old children with cowâs milk allergy. Clinical and Experimental Allergy 41: 1297-1304. https://doi.org/10.1111/j.1365-2222.2011.03749.x
-
Nagakura, K.I., Sato, S., Miura, Y., Nishino, M., Takahashi, K., Asaumi, T., Ogura, K., Ebisawa, M. and Yanagida, N., 2021. A randomized trial of oral immunotherapy for pediatric cowâs milk-induced anaphylaxis: heated vs unheated milk. Pediatric Allergy and Immunology 32: 161-169. https://doi.org/10.1111/pai.13352
-
Odamaki, T., Xiao, J.-Z., Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H. and Enomoto, T., 2007. Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season. Journal of Medical Microbiology 56: 1301-1308.
'Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season ' () 56 Journal of Medical Microbiology : 1301 -1308.
-
Peng, G.C. and Hsu, C.H., 2005. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatric Allergy and Immunology 16: 433-438. https://doi.org/10.1111/j.1399-3038.2005.00284.x
-
Plessas, S., Bosnea, L., Alexopoulos, A. and Bezirtzoglou, E., 2012. Potential effects of probiotics in cheese and yogurt production: a review. Engineering in Life Sciences 12: 433-440. https://doi.org/https://doi.org/10.1002/elsc.201100122
-
Prescott, S.L., Pawankar, R., Allen, K.J., Campbell, D.E., Sinn, J., Fiocchi, A., Ebisawa, M., Sampson, H.A., Beyer, K. and Lee, B.W., 2013. A global survey of changing patterns of food allergy burden in children. World Allergy Organization Journal 6: 21. https://doi.org/10.1186/1939-4551-6-21
-
Sampson, H.A., Gerth van Wijk, R., Bindslev-Jensen, C., Sicherer, S., Teuber, S.S., Burks, A.W., Dubois, A.E.J., Beyer, K., Eigenmann, P.A., Spergel, J.M., Werfel, T. and Chinchilli, V.M., 2012. Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology â European Academy of Allergy and Clinical Immunology PRACTALL consensus report. Journal of Allergy and Clinical Immunology 130: 1260-1274. https://doi.org/10.1016/j.jaci.2012.10.017
-
Savage, J.H., Lee-Sarwar, K.A., Sordillo, J., Bunyavanich, S., Zhou, Y., OâConnor, G., Sandel, M., Bacharier, L.B., Zeiger, R., Sodergren, E., Weinstock, G.M., Gold, D.R., Weiss, S.T. and Litonjua, A.A., 2018. A prospective microbiome-wide association study of food sensitization and food allergy in early childhood. Allergy 73: 145-152. https://doi.org/10.1111/all.13232
-
Schülke, S., 2018. Induction of interleukin-10 Producing dendritic cells as a tool to suppress allergen-specific T helper 2 Responses. Frontiers in Immunology 9: 455. https://doi.org/10.3389/fimmu.2018.00455
-
Shida, K., Nanno, M. and Nagata, S., 2011. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2: 109-114. https://doi.org/10.4161/gmic.2.2.15661
-
Stephen-Victor, E., Crestani, E. and Chatila, T.A., 2020. Dietary and Microbial Determinants in Food Allergy. Immunity 53: 277-289. https://doi.org/https://doi.org/10.1016/j.immuni.2020.07.025
-
Sugiura, S., Kitamura, K., Makino, A., Matsui, T., Furuta, T., Takasato, Y., Kando, N. and Ito, K., 2020. Slow low-dose oral immunotherapy: threshold and immunological change. Allergology International 69: 601-609. https://doi.org/10.1016/j.alit.2020.03.008
-
Suzuki, S., Kubota, N., Kakiyama, S., Miyazaki, K., Sato, K. and Harima-Mizusawa, N., 2020. Effect of Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis and regulatory T cells in adults. Allergy 75: 453-456. https://doi.org/10.1111/all.14003
-
Tan-Lim, C.S.C. and Esteban-Ipac, N.A.R., 2018. Probiotics as treatment for food allergies among pediatric patients: a metaanalysis. World Allergy Organization Journal 11: 25. https://doi.org/10.1186/s40413-018-0204-5
-
Thakur, B.K., Saha, P., Banik, G., Saha, D.R., Grover, S., Batish, V.K. and Das, S., 2016. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response. International Immunopharmacology 36: 39-50. https://doi.org/10.1016/j.intimp.2016.03.033
-
Thomas, L.V., Ockhuizen, T. and Suzuki, K., 2014. Exploring the influence of the gut microbiota and probiotics on health: a symposium report. British Journal of Nutrition 112: S1-S18. https://doi.org/10.1017/S0007114514001275
-
Van Splunter, M., Liu, L., van Neerven, R.J.J., Wichers, H.J., Hettinga, K.A. and De Jong, N.W., 2020. Mechanisms Underlying the skin-gut cross talk in the development of IgE-mediated food allergy. Nutrients 12: 3830. https://doi.org/10.3390/nu12123830
-
Wang, Z., Zhong, J., Meng, X., Gao, J., Li, H., Sun, J., Li, X. and Chen, H., 2021. The gut microbiome-immune axis as a target for nutritionmediated modulation of food allergy. Trends in Food Science & Technology 114: 116-132. https://doi.org/https://doi.org/10.1016/j.tifs.2021.05.021
-
Wood, R.A., Sicherer, S.H., Vickery, B.P., Jones, S.M., Liu, A.H., Fleischer, D.M., Henning, A.K., Mayer, L., Burks, A.W., Grishin, A., Stablein, D. and Sampson, H.A., 2013. The natural history of milk allergy in an observational cohort. Journal of Allergy and Clinical Immunology 131: 805-812. https://doi.org/10.1016/j.jaci.2012.10.060
-
Yamamoto-Hanada, K., Pak, K., Saito-Abe, M., Yang, L., Sato, M., Irahara, M., Mezawa, H., Sasaki, H., Nishizato, M., Ishitsuka, K., Ohya, Y., Kamijima, M., Yamazaki, S., Ohya, Y., Kishi, R., Yaegashi, N., Hashimoto, K., Mori, C., Ito, S., Yamagata, Z., Inadera, H., Nakayama, T., Iso, H., Shima, M., Kurozawa, Y., Suganuma, N., Kusuhara, K. and Katoh, T., 2020. Allergy and immunology in young children of Japan: the JECS cohort. World Allergy Organization Journal 13: 100479. https://doi.org/10.1016/j.waojou.2020.100479
-
Yeung, J.P., Kloda, L.A., McDevitt, J., Ben-Shoshan, M. and Alizadehfar, R., 2012. Oral immunotherapy for milk allergy. Cochrane Database of Systematic Reviews 11: Cd009542. https://doi.org/10.1002/14651858.CD009542.pub2
Supplementary Materials
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 0 | 0 | 0 |
| Gesamttextansichten | 1306 | 363 | 39 |
| PDF-Downloads | 1617 | 466 | 30 |
Combination of heat-killed Lactiplantibacillus plantarum YIT 0132 (LP0132) and oral immunotherapy in cowâs milk allergy: a randomised controlled trial
in Beneficial MicrobesSearch for other papers by K. Yamamoto-Hanada in
Current site
Google Scholar
PubMed
Search for other papers by M. Sato in
Current site
Google Scholar
PubMed
Search for other papers by K. Toyokuni in
Current site
Google Scholar
PubMed
Search for other papers by M. Irahara in
Current site
Google Scholar
PubMed
Search for other papers by E. Hiraide-Kotaki in
Current site
Google Scholar
PubMed
Search for other papers by N. Harima-Mizusawa in
Current site
Google Scholar
PubMed
Search for other papers by H. Morita in
Current site
Google Scholar
PubMed
Search for other papers by K. Matsumoto in
Current site
Google Scholar
PubMed
Search for other papers by Y. Ohya in
Current site
Google Scholar
PubMed
Safer and more effective cow milk (CM)-oral immunotherapy that does not induce allergic reactions has not yet been standardised. We sought to explore the efficacy and feasibility of a combination of heat-killed Lactiplantibacillus plantarum YIT 0132 (LP0132) and oral immunotherapy for treating IgE-mediated cow milk allergy (CMA). We conducted a 24-week, double-blind, randomised (1:1), two-arm, parallel-group, placebo-controlled, phase 2 trial of LP0132 intervention for treating IgE-mediated CMA in children aged 1-18 years (n=60) from January 29, 2018 to July 12, 2019 in Tokyo, Japan. Participants were randomly assigned to the LP0132 group receiving citrus juice fermented with LP0132 or to the control group receiving citrus juice without. Both groups received low-dose slow oral immunotherapy with CM. The primary outcome was improved tolerance to CM, proven by the CM challenge test at 24 weeks. Secondary outcomes were changes in serum biomarkers of serum-specific β-lactoglobulin-IgE (sIgE) and β-lactoglobulin-IgG4 (sIgG4). Exploratory outcomes included changes in serum cytokine levels and gut microbiota composition. A total of 61 participants were included. Finally, 31 children were assigned to the LP0132 group and 30 to the control group, respectively. After the intervention, 41.4 and 37.9% of the participants in the LP0132 and control groups, respectively, showed improved tolerance to CM. In serum biomarkers after the intervention, the sIgG4 level was significantly higher, and interleukin (IL)-5 and IL-9 were significantly lower, in the LP0132 group than in the control group. In the gut microbiome, the α-diversity and Lachnospiraceae increased significantly in the LP0132 group, and Lachnospiraceae after the intervention was significantly higher in the LP0132 group than in the control group. In conclusion, low-dose oral immunotherapy with modulating gut microbiota might be a safer and more effective approach for treating cowâs milk allergy.
| Insgesamt | Letzte 365 Tage | In den letzten 30 Tagen | |
|---|---|---|---|
| Aufrufe von Kurzbeschreibungen | 0 | 0 | 0 |
| Gesamttextansichten | 1306 | 363 | 39 |
| PDF-Downloads | 1617 | 466 | 30 |
